BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

20212,787 citationsJournal Articlegreen Open Access

Authors

Noa Dagan · Clalit Health Services

Noam Barda · Clalit Health Services

Eldad Kepten · Clalit Health Services

Oren Miron · Clalit Health Services

Shay Perchik · Clalit Health Services

Mark A. Katz · Clalit Health Services

Miguel A. Hernán ·

Abstract

This study in a nationwide mass vaccination setting suggests that the BNT162b2 mRNA vaccine is effective for a wide range of Covid-19-related outcomes, a finding consistent with that of the randomized trial.

Topics & Keywords

SARS-CoV-2 and COVID-19 Research COVID-19 Impact on Reproduction Vaccine Coverage and Hesitancy

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 384, Issue 15, pp. 1412-1423

DOI: 10.1056/nejmoa2101765

Field-Weighted Citation Impact: 170.74